共 50 条
- [32] Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies FRONTIERS IN ONCOLOGY, 2019, 9
- [35] Epigenetic programming contributes to development of drug resistance in hematological malignancies FRONTIERS IN BIOSCIENCE-LANDMARK, 2015, 20 : 728 - 742
- [36] Epigenetic inactivation of the MIR129-2 in hematological malignancies Journal of Hematology & Oncology, 6